We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$367M
AUM Growth
-$15.4M
Cap. Flow
-$423K
Cap. Flow %
-0.12%
Top 10 Hldgs %
41.26%
Holding
60
New
5
Increased
26
Reduced
17
Closed
3

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$10.9M
2
ALLE icon
Allegion
ALLE
+$6.16M
3
HSIC icon
Henry Schein
HSIC
+$2.93M
4
FISV
Fiserv Inc
FISV
+$2.47M
5
EXPE icon
Expedia Group
EXPE
+$2.42M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$10.4M
2
UNVR
Univar Solutions Inc.
UNVR
+$9.07M
3
VMW
VMware, Inc
VMW
+$4.54M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.83M
5
RTX icon
RTX Corp
RTX
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 25.4%
2 Healthcare 19.61%
3 Financials 14.31%
4 Consumer Staples 14.3%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLE icon
26
Allegion
ALLE
$13.4B
$5.7M 1.56%
+54,750
New +$6.16M
TFC icon
27
Truist Financial
TFC
$63.3B
$5.56M 1.52%
194,266
-24,762
-11% -$761K
AON icon
28
Aon
AON
$76.5B
$5.41M 1.47%
16,671
-3,438
-17% -$1.14M
KO icon
29
Coca-Cola
KO
$377B
$5.25M 1.43%
93,720
– –
AOS icon
30
A.O. Smith
AOS
$8.17B
$5.12M 1.39%
77,352
+1,869
+2% +$133K
SEIC icon
31
SEI Investments
SEIC
$12.4B
$5.09M 1.39%
84,489
+5,964
+8% +$367K
OTIS icon
32
Otis Worldwide
OTIS
$27.4B
$4.48M 1.22%
55,823
+14
+0% +$1.2K
WTW icon
33
Willis Towers Watson
WTW
$31.2B
$4.38M 1.19%
20,970
+3,091
+17% +$660K
PEP icon
34
PepsiCo
PEP
$190B
$4.34M 1.18%
25,623
-3,608
-12% -$655K
LHX icon
35
L3Harris
LHX
$51.6B
$4.32M 1.18%
24,792
+2,967
+14% +$546K
CDW icon
36
CDW
CDW
$18.9B
$3.88M 1.06%
19,207
+1,316
+7% +$262K
ULTA icon
37
Ulta Beauty
ULTA
$22B
$3.82M 1.04%
9,573
-558
-6% -$244K
CME icon
38
CME Group
CME
$96.3B
$3.64M 0.99%
18,168
+5,319
+41% +$1.06M
UNP icon
39
Union Pacific
UNP
$174B
$3.45M 0.94%
16,962
-540
-3% -$118K
SONY icon
40
Sony
SONY
$137B
$3.36M 0.92%
203,805
+9,530
+5% +$166K
WMT icon
41
Walmart Inc
WMT
$885B
$3.19M 0.87%
59,850
– –
HSIC icon
42
Henry Schein
HSIC
$9.77B
$2.82M 0.77%
+37,988
New +$2.93M
V icon
43
Visa
V
$684B
$2.56M 0.7%
11,123
+1,295
+13% +$311K
SNY icon
44
Sanofi
SNY
$103B
$2.29M 0.62%
42,663
+3,085
+8% +$164K
PFE icon
45
Pfizer
PFE
$143B
$2.28M 0.62%
68,765
+8,113
+13% +$287K
EXPE icon
46
Expedia Group
EXPE
$35.4B
$2.26M 0.62%
+21,922
New +$2.42M
ABBV icon
47
AbbVie
ABBV
$443B
$1.82M 0.5%
12,242
– –
RTX icon
48
RTX Corp
RTX
$290B
$1.2M 0.33%
16,615
-21,753
-57% -$1.86M
ABT icon
49
Abbott
ABT
$183B
$1.18M 0.32%
12,200
– –
UL icon
50
Unilever
UL
$137B
$1.14M 0.31%
20,569
-444
-2% -$25.7K
1
2
3

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q3 2023 Portfolio in Review

As of Q3 2023, Foyston, Gordon, & Payne held 60 positions worth $367M, down 4% from $382M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foyston, Gordon, & Payne's Q3 2023 filing shows 5 new, 26 increased, 17 reduced and 3 closed positions. Its largest new stake was Kenvue: 472,720 shares worth $9.49M. The largest sale was Novartis, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne's largest Q3 2023 buy was Kenvue: 472,720 shares worth $9.49M.
  • Foyston, Gordon, & Payne added most to Fiserv Inc in Q3 2023, an estimated $2.47M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2023 reduction was Novartis, cutting an estimated $10.4M.
  • Foyston, Gordon, & Payne fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $9.07M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 41% of its $367M portfolio in Q3 2023.
  • Foyston, Gordon, & Payne opened 5 new positions and closed 3 in Q3 2023.
  • Foyston, Gordon, & Payne's portfolio value fell 4% quarter-over-quarter to $367M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2023, filed 26 Oct 2023.